期刊文献+

壳聚糖衍生物作为siRNA纳米递送系统材料的研究进展 被引量:2

Research Progress of Chitosan Derivatives as Materials for siRNA Nano-delivery Systems
原文传递
导出
摘要 小干扰RNA(small interfering RNA,siRNA)在治疗疾病方面具有高效性、特异性、瞬时性等优良特性,是目前药物研发关注的焦点。但裸露的siRNA稳定性差、细胞摄取率低,难以发挥其基因沉默作用,因此需要一种优质的递送系统将其递送至靶细胞中,使其发挥作用。大部分纳米递送系统因毒性、载药问题不利于siRNA的转运,而壳聚糖衍生物具有较高的水溶性、安全性、稳定性,已受到广泛关注。本文综述了壳聚糖衍生物应用于siRNA纳米递送系统的研究进展,为正在进行纳米递送系统研究的科研工作者提供参考。 Small interfering RNA(siRNA)has been the focus of attention in the field of drug development for its excellent properties such as efficiency,specificity and transient nature in treating diseases.However,the poor stability and low cellular uptake of naked siRNAs make it difficult for them to exert their gene silencing effects,a high-quality drug delivery system is needed to deliver them to target cells where they can function.Many nano delivery systems are no longer suitable for siRNA transport due to toxicity and drug loading problems,chitosan derivatives are beginning to receive widespread attention because of their high water solubility,safety and stability.This paper reviewed the research progress of chitosan derivatives as siRNA nano-delivery systems and provided a reference for researchers who are interested in the development of nano-delivery systems.
作者 熊峰 苏峰 曹俊如 储晓琴 何广卫 XIONG Feng;SU Feng;CAO Junru;CHU Xiaoqin;HE Guangwei(Anhui University of Chinese Medicine,Hefei 230012,China;Hefei Industrial Pharmaceutical Institute Co.,Ltd.,Hefei 230088,China;China Pharmaceutical University,Nanjing 211198,China;Anhui Medical University,Hefei 230032,China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2023年第13期1889-1896,共8页 Chinese Journal of Modern Applied Pharmacy
关键词 SIRNA 递送系统 基因沉默 壳聚糖衍生物 siRNA delivery system gene silencing chitosan derivatives
  • 相关文献

参考文献4

二级参考文献47

  • 1Nitin Bharat Charbe,Nikhil D.Amnerkar,B.Ramesh,Murtaza M.Tambuwala,Hamid A.Bakshi,Alaa A.A.Aljabali,Saurabh C.Khadse,Rajendran Satheeshkumar,Saurabh Satija,Meenu Metha,Dinesh Kumar Chellappan,Garima Shrivastava,Gaurav Gupta,Poonam Negi,Kamal Dua,Flavia C.Zacconin.Small interfering RNA for cancer treatment:overcoming hurdles in delivery[J].Acta Pharmaceutica Sinica B,2020,10(11):2075-2109. 被引量:19
  • 2Harborth J, Elbashir SM. Bechert K. et al. Identification of essential genes in cultured mammalian cells using small interfering RNAs[J]. J Cell Sci, 2001, 114(24):4557.
  • 3Cogoni C, Romano N, Macino G. Suppression of gene expression by homologus trans-genes[J]. Antonie Van Leeu wenhoek 1994, 65(3) :205.
  • 4Guo S, Kempheus KJ. PAR1, A gene required for establis hing polarity in C. elegans embryos, encodes a putative Ser/ Thr kinase that is asymmetrically distribute[J]. Cell, 1995, 81:611.
  • 5Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J]. Nature, 1998, 391(6669) :806.
  • 6Hannon GJ. RNA interference [J]. Nature, 2002, 418 (6894):244.
  • 7Kloosterman WP, Plasterk RH. The diverse functins of microRNAs in animal development and disease.[J].Dev Cell, 2006, 11:441.
  • 8Tuseshl T, Zamore PD, Lehmann R, et al. Targeted mRNA degradation by double-stranded RNA in vitro[J]. Genes Dev, 1999, 13(24):3191.
  • 9Peters L, Meister G. Argonaute proteins:Mediators of RNA silencing. [J].Mol Cell, 2007, 26: 611.
  • 10Reinhartrt HJ, Slack FJ. Basson M, et al. The 21-nucleotide let - 7 RNA regulates developmental timing in Caenorhabditis. [J]. Nature, 2000,403:901.

共引文献41

同被引文献18

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部